A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Chung, C.H. ; Lee, J.W. ; Slebos, R.J. ; Howard, J.D. ; Perez, J. ; Kang, H. ; Fertig, E.J. ; Considine, M. ; Gilbert, J. ; Murphy, B.A. ; Nallur, S. ; Paranjape, T. ; Jordan, R.C. ; Garcia, J. ; Burtness, B. ; Forastiere, A.A. ; Weidhaas, J.B.

Annals of oncology, 2014-11, Vol.25 (11), p.2230-2236 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível